Multiple system atrophy (MSA) is an adult-onset, rapidly progressive neurodegenerative disorder characterised by the aggregation of α-synuclein in oligodendroglial cytoplasmatic inclusions.1 ...
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced additional positive results from the pivotal study of zilganersen in children and adults living with Alexander disease (AxD), a rare, ...
ASTANA – Kazakhstan’s national oil and gas company KazMunayGas (KMG) has presented its large-scale geological exploration ...
Investing.com -- Arcus Biosciences Inc. (NASDAQ:RCUS) shares fell 4% Monday after the company announced the discontinuation ...
Cancer-focused biotech, Arcus Biosciences, Inc. RCUS stock is trading higher on Wednesday after the company’s stock closed ...
MedPage Today on MSN
Mobile Intervention Helps Moms With Obesity Reduce Gestational Weight Gain
Intervention uses a smartphone app to promote healthy eating and increased activity ...
A phase 1/2 trial shows strong early efficacy for daraxonrasib plus chemotherapy as first-line treatment for patients with metastatic pancreatic cancer — but toxicity is a concern.
On behalf of Pulsar Helium Inc. “Thomas Abraham-James” CEO and Director ...
The Securities and Exchange Commission just opened the floodgates for public comment on its Consolidated Audit Trail. Big ...
Issued on behalf of VisionWave Holdings, Inc., Starfighters Space, Inc., Avaí Bio, Inc., Lake Victoria Gold Ltd., and QSE – Quantum Secure ...
The absence of escalation reduces immediate risk, but does not imply progress. A single material concession, on the other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results